Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
04/24ONCOSEC MEDICAL : Announces Triple Combination Immunotherapy Clinical Trial Of TAVO(TM), Epacadostat And KEYTRUDA In Squamous Cell Head And Neck (SCCHN) Cancer
AQ
04/24ELI LILLY AND : Lilly Announces Sale of Legacy Antibiotics Brands and Manufacturing Facility in China
AQ
04/24TELIGENT : Technology Provider Teligent Systems Becomes a WSO2 Value-Added Reseller in the Philippines
AQ
04/24ADURO BIOTECH : Pfizer oncology executive hops over to Aduro as its new chief medical officer
AQ
04/24GN STORE NORD : Reduction of GN Store Nords share capital
AQ
04/24KAROLINSKA DEVELOPMENT : portfolio company Dilafor secures financing for continued development of tafoxiparin
AQ
04/24GUARDANT HEALTH : Appoints Dr. Bahija Jallal to its Board of Directors
AQ
04/24GLYCOMIMETICS : Announces Enrollment of First Patient in NCI-Sponsored Phase 3 Trial of Uproleselan in AML
AQ
04/24BIOELECTRONICS : Responds to FDAs 510(k) Additional Information Requests for its Musculoskeletal Pain Relief and Postoperative Pain Applications
AQ
04/24APTORUM : Establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and Unmet Diseases
BU
04/24APTORUM : Smart Pharma announces launch of its asset backed Smart Pharma token (SMPT), supported by its computational repurposed drug discovery platform Smart-ACT™
BU
04/24IMMUNOVIA PUBL : Interim Report, January-March 2019
AQ
04/24PURETECH HEALTH : Announces Annual Results for Year Ended 31 December 2018
PU
04/24BIOTAGE : Hydrolyze Urine Samples In-Situ - New Application Note
PU
04/24APTORUM GROUP LIMITED : Announces Repurchase of USD13,500,000 Outstanding Convertible Bonds Due 2019
BU
Discover
04/24ChromaDex Furthers TRU NIAGEN® Global Expansion in Canada with WELL Health Technologies
GL
04/24Q & M DENTAL SINGAPORE : Disclosure Of Changes In Interest Of Director And Chief Executive Officer - Dr Ng Chin Siau
PU
04/24INTEGRA : 1Q Earnings Snapshot
AQ
04/24DAVITA : The Aspen Group Applauds the New Payment Model Pilots Introduced by the Center for Medicare & Medicaid Innovation
PU
04/24ABIOMED INC : Other Events (form 8-K)
AQ
04/24INTEGRA LIFESCIENCES HOLDINGS CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
04/24THERMO FISHER : 1Q Earnings Snapshot
AQ
04/24ANTHEM : Insurer Anthem tops 1Q expectations, raises 2019 forecast
AQ
04/24ANTHEM, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
04/24MOLECULIN BIOTECH, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
04/24CANCER GENETICS : DNA Rearrangement May Predict Resistance in Multiple Myeloma
AQ
04/24DAVITA : Helping Patients Along Their Kidney Transplant Journey
PR
04/24ANTHEM : Reports First Quarter 2019 Results, Raises Full Year Outlook
BU
04/24UNITED THERAPEUTICS CORPORATION : To Report First Quarter 2019 Financial Results Before The Market Opens On Wednesday, May 1, 2019
PR
04/24THERMO FISHER SCIENTIFIC : Reports First Quarter 2019 Results
PR
04/24Integra LifeSciences Reports First Quarter 2019 Financial Results
GL
04/24AXONICS MODULATION TECHNOLOGIES : ® to Report First Quarter 2019 Financial Results and Host a Conference Call on May 8
BU
04/24MOLOGEN AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
04/24NOVARTIS : 1Q Earnings Snapshot
AQ
04/24UNITEDHEALTH : Despite talk of universal health care, UnitedHealth a robust stock
AQ
04/24MERIT MEDICAL SYSTEMS, INC. (NASDAQ : MMSI) Files An 8-K Results of Operations and Financial Condition
AQ
04/24EISAI : to Present Latest Data on Lemborexant and Perampanel at Annual American Academy of Neurology Meeting
AQ
04/24ATTENDO PUBL : report for the first quarter 2019 to be published on 3 May - Invitation to teleconference
AQ
04/24BERGENBIO ASA : Invitation to First Quarter Presentation and Webcast
AQ
04/24AQUABOUNTY TECHNOLOGIES, INC. (LON : ABTU) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
AQ
04/24LHC : LIFE HEALTHCARE GROUP HOLDINGS LIMITED - Trading statement
PU
04/24EL EN : Notice to Shareholders
PU
04/24PHYLOGICA : Change of Director's Interest Notice
PU
04/24PW MEDTECH : Circulars
PU
04/24SHIELD THERAPEUTICS : STX); Swissmedic approves major extension of Feraccru in Switzerland
AQ
04/24VOLITIONRX : Executive Interview - VolitionRx (VNRX)
AQ
04/24AXOGEN : shares slip on expanded Avance nerve graft study
AQ
04/24MICROBOT MEDICAL : Strengthens Global IP Portfolio with Canadian Notice of Allowance for a Patent Application for a Shunt Stenosis Prevention System
AQ
04/24MALLINCKRODT : Lupus Phase 4 Clinical Study for Acthar Gel (Repository Corticotropin Injection) Completes Enrollment in Difficult-to-Manage Population
AQ
04/24ATHERSYS : HEALIOS K.K. Announces Enrollment of First Patient in Japan in the ONE-BRIDGE Study of MultiStem Treatment for Acute Respiratory Distress Syndrome
AQ
04/24UROGEN PHARMA : Announces Early Stage Feasibility Agreement with Janssen
AQ
04/24TROVAGENE : Announces Data Demonstrating Significant Synergy of Onvansertib in Combination with Venetoclax in Cell Model of Venetoclax-Resistant AML
AQ
04/24AKARI THERAPEUTICS : Announces Positive Initial Phase II Clinical Data in Orphan Skin Disease Bullous Pemphigoid
AQ
04/24ARCA BIOPHARMA : Announces Steering Committee of Leading International Cardiology and Electrophysiology Experts for PRECISION-AF Phase 3 Clinical Trial
AQ
04/24VERITAS FARMS : Appoints Michael D. Pelletier as Chief Financial Officer
AQ
04/24BRIACELL THERAPEUTICS : Announces Publication at American Society of Clinical Oncology (ASCO) Meeting and Presentation at Precision Breast Cancer Summit in Boston
AQ
04/24LABORATORY OF AMERICA : OmniSeq and LabCorp Extend Exclusive Distribution Pact and Complete Follow-On Investment Agreement
AQ
04/24PLURISTEM THERAPEUTICS : Issues Shareholder Update
AQ
04/24LABORATORY OF AMERICA : OmniSeq and LabCorp Extend Exclusive Distribution Pact and Complete Follow-On Investment Agreement
AQ
04/24PROMIS NEUROSCIENCES : to Participate in the Think Equity Investor Conference
AQ
04/24AZURRX BIOPHARMA : Exceeds 50% Enrollment Target for Phase II OPTION Clinical Trial
AQ
04/24OPTIMIZERX : to Present at Investor Conferences in May
AQ
04/24YIELD GROWTH : Application for new INCI name granted for Yield Growths Cannabis Sativa Hemp Root Oil made with Patent Pending Technology
AQ
04/24AMERICAN RENAL ASSOCIATES : FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARA, NTNX, BA and APYX
AQ
04/24BIOCARTIS GROUP NV : Biocartis Announces Global Collaboration with Covance
AQ
Discover
04/24INVENTIVA : to present new results of its YAP-TEAD oncology program at the AACR Special Conference on The Hippo Pathway
AQ
04/24BOSTON SCIENTIFIC CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
04/24BOSTON SCIENTIFIC : Announces Results For First Quarter 2019
PR
04/24Precision BioSciences Announces Presentations at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy
GL
04/24RA PHARMACEUTICALS : Presents Pre-Clinical Data for Zilucoplan XR at the 6th Annual Peptides Congress
BU
Prev.4  5  6  7  8   9  10  11  12  13Next
Advertisement